Diabetes and cardiometabolic marketing requires a consistent flow of ad and brand creative, yet every asset must be compliant, authentic, and sensitive to how people really live with these conditions. We create a production engine that delivers volume without running into a compliance wall.
Every asset makes a claim, and higher volume compounds the review burden
Performance marketing needs a constant stream of creative to fight fatigue, but in this category every headline, visual, and testimonial is a claim that needs review. Teams either produce enough volume and let compliance risk slip through, or review everything carefully and cannot keep up with the feed. Producing compliant creative at performance volume is an operational problem most creative shops are not built to solve.
Stock-photo health creative feels fake to those living with the condition
People managing diabetes or heart disease immediately spot the glossy, unrealistic stock imagery that pervades health marketing, and it signals a company that does not understand them. Authentic, respectful creative that reflects real life with a chronic condition builds trust, while generic health stock actively erodes it. Producing creative that feels real to this audience takes intent and sensitivity, not a stock library.
Testimonials and before-afters are a minefield rather than an easy win
Patient testimonials and transformation stories are powerful but heavily regulated – implied typical results, unsubstantiated outcomes, and privacy issues turn a compelling asset into a liability. Creative teams without a framework either avoid this high-performing format entirely or use it in ways that create risk. Handling patient stories compliantly is a specialized skill that determines whether you can use one of the category's best-performing formats at all.
Slow, one-off production cannot support a true performance program
When each asset is produced as a bespoke project with a long compliance loop, you cannot generate the creative volume performance channels demand, and fatigue kills your campaigns. The bottleneck is rarely a single ad – it is the absence of a system that produces compliant variations quickly. Without a production engine, creative becomes the constraint that caps your entire paid program.
We begin by identifying what your channels truly require – the formats, volume, and refresh cadence that keep performance campaigns moving – alongside the claim boundaries each asset must follow, so production accounts for both from day one. This ties into our broader [growth strategy](/services/strategy/) work, ensuring creative supports the media plan instead of lagging behind it.
Strategy creates the production system, not merely standalone assets: templates, modular claim-safe components, and an approval process with compliance embedded, allowing us to deliver compliant variations at scale rather than handling every ad as a custom project with a lengthy review cycle. This removes the creative bottleneck that limits paid programs.
Execution delivers the creative through our [creative](/services/creative/) practice – ad and brand assets grounded in the reality of living with a chronic condition rather than polished health stock, with each claim checked against your regulatory boundaries. We embed the sensitivity and realism that build trust among people managing diabetes or heart disease into the creative process itself.
We also create a compliant structure for difficult, high-performing formats – patient testimonials and transformation stories – including the substantiation, disclosure, and privacy safeguards needed to use them safely rather than sidestep them. This opens access to some of the category's strongest-performing creative without adding liability.
Throughout the process, creative production connects to testing and performance data via our [measurement](/services/measurement/) layer, so we scale what succeeds and retire what does not instead of relying on guesswork. Volume matters only when directed toward assets that genuinely perform.
We do not simply deliver a batch of one-off ads – we create a production engine that maintains compliant volume for a genuine performance program.
In diabetes and cardiometabolic marketing, each asset is both a creative choice and a compliance decision – meaning what truly limits your paid program is not one ad, but the lack of a production system capable of creating compliant, authentic variations quickly enough to combat fatigue.
Our 90-day sprint creates a production engine for creative in a regulated health category. Days 1-30 focus on assessment: we map the formats and volume your channels require, establish with your compliance input the claim boundaries every asset must follow, audit where existing creative feels generic or introduces risk, and design the production system. The phase concludes with a production plan and claim-safe component framework.
Days 31-60 focus on building the engine and creating assets. We establish templates, modular components, and a compliance-integrated approval process, then deliver the first wave of authentic, compliant ad and brand creative – including a safe structure for testimonials and transformation stories. Claims are checked against your regulatory boundaries during production, not afterward.
Days 61-90 cover optimization and handoff. We connect production with testing and performance data to direct volume toward what works, improve the templates and workflow, and document the system so your team can operate it. Since performance creative is an ongoing requirement, the sprint puts a sustainable engine in place rather than delivering a one-time ad batch.
During the first 30 days, we partner with your growth lead and compliance reviewer because the production system must support the media plan while honoring claim boundaries. Expect working sessions focused on mapping channel requirements, defining claim-safe components, and assessing where existing creative feels generic or risky.
Days 30-60 shift to constructing the engine and producing creative. Instead of making one-off assets, we establish templates and a compliance-integrated workflow, then create authentic, compliant work that includes a safe testimonial framework. Claim review is treated as part of production, ensuring nothing ships unless it can be defended.
Days 60-90 center on optimization and handoff. We link production with testing to create more of what performs, refine the system, and transfer it to your team. Because performance channels require a steady stream of fresh creative, most engagements last 4-6 months to establish a sustainable engine instead of delivering one production burst.
The team includes a strategist responsible for the production system and claim framework, creative specialists producing authentic, compliant assets, and a measurement resource connecting production with performance – all scaled to your creative volume rather than a preset package.
If your diabetes & cardiometabolic health company needs creative production leadership, we should talk.
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Engagements generally range from $12K-$30K/month based on the creative volume and mix of formats your channels require. Pricing scales according to production throughput and compliance-workflow complexity rather than a set asset count. Since creative volume directly limits paid-program performance, the investment is evaluated against the fatigue reduction and efficiency gains that a consistent, compliant supply brings to your media spend.
We create a production system – templates, modular claim-safe components, and an approval process with compliance embedded – that generates compliant variations quickly instead of approaching every ad as a custom project. This system allows review and volume to coexist without forcing a tradeoff. In this category, the bottleneck is seldom one ad; it is usually the missing system, which is precisely what we install.
We produce creative that represents the realities of living with a chronic condition – respectful, specific, and realistic – because people managing diabetes or heart disease quickly recognize glossy, unrealistic health stock, which undermines trust. Authenticity is built into the creative process rather than applied afterward. That realism is a significant reason creative builds trust in this category instead of alienating its audience.
Yes, through a compliant framework covering substantiation, implied typical results, disclosure, and patient privacy, enabling you to use these high-performing formats rather than steer clear of them. Without this framework, testimonials and before-afters can shift from valuable assets to liabilities. Creating a safe way to use them is a specialized capability that determines whether one of the category's strongest formats is available to you at all.
We connect production to testing and performance data, allowing us to scale what works and retire what does not rather than create volume simply for volume's sake. Volume is valuable only when focused on assets that genuinely perform. This link keeps the engine efficient instead of overwhelming channels with creative that fails to convert.
We start by identifying what your channels require, establishing claim boundaries with your compliance team, and reviewing where current creative feels generic or presents risk. This produces a clear production plan and claim-safe component framework before we construct the engine. If limited creative volume is constraining your diabetes or cardiometabolic paid program, we should talk.
Tuesday, September 8, 2026
Frank Growth – Episode 236 – Turn Marketers Into AI Strategists with Elyssa Steiner
Tuesday, June 16, 2026
Frank Growth – Episode 224 – The Bootstrapper’s Revenge with Alex Roy
Tuesday, July 21, 2026
Frank Growth – Episode 229 – Longevity Medicine’s Dirty Secret with Jim Donnelly
Tuesday, September 1, 2026
Frank Growth – Episode 235 – The Marketing Engineer with Nick Lafferty
Ready to unlock your growth?
Book Free Call